Published in Hospital Law Weekly, May 24th, 2007
Growing demands from regulators for postmarket-approval data along with the need for data to support commercial markets are fueling biotech company product and disease registries. This session will guide participants through the decision-making, structuring, legal/regulatory, implementation and operational components of establishing and operating a global product/disease registry.
Topics covered will include:
Understanding when a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.